Clinical Trial Endpoints

Clinical trials in inherited retinal disease need outcome measures that are sensitive to meaningful change and interpretable across patients, visits, and modalities.

This project area brings together endpoint ranking, longitudinal modelling, visual function testing, and retinal imaging summaries to help identify measures that are robust enough for treatment evaluation.